Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new strain of
coronavirus and the causative agent of the current global pandemic of coronavirus disease …

Since the end of 2019, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
spread as a new strain of coronavirus disease (COVID‐19) and progressed as a global …

Efforts to discover antiviral drugs and diagnostic platforms have intensified to an
unprecedented level since the outbreak of COVID-19. Nano-sized endosomal vesicles …

There are no commercially available effective antiviral medications or vaccines to deal with
novel coronavirus disease (COVID-19). Hence there is a substantial unmet medical need for …

The novel coronavirus severe acute respiratory syndrome-CoV-2 (SARS-CoV-2) is
responsible for COVID-19 infection. The COVID-19 pandemic represents one of the worst …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is causing an ongoing
pandemic of coronavirus disease 2019 (Covid‐19). Effective therapies are required for the …

Exosomes are messengers of intercellular communication in monolayer vesicles derived
from cells. It affects the pathophysiological process of the body in various diseases, such as …

Extracellular vesicles releasing from various types of cells contribute to intercellular
communication via delivering bio-molecules like nucleic acids, proteins, and lipids to …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global pandemic
in the years 2020–2022. With a high prevalence, an easy route of transmission, and a long …

Background The outbreak of a new virus known as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has now become the main health concern all over the world …